President Obama’s Precision Medicine Initiative could prove significant for the pharma industry, if the details prove as enticing as the idea suggests.
In his State of the Union address Jan. 20, Obama announced the Precision Medicine Initiative “to bring us closer to curing diseases like cancer and diabetes, and to give all...